Clinical Trial Update: Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy of combined L-ornithine-L-aspartate with lactulose for hepatic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• L-ornithine-L-aspartate (L-ornithine-L-aspartate)
• LACTULOSE (Lactulose)

Snippet

Sponsor: Mahidol University | Conditions: Hepatic Encephalopathy | Phase 4 | Status: COMPLETED